openPR Logo
Press release

SMi's Paediatric Clinical Trials conference held on the 21st & 22nd March 2012, London

11-25-2011 06:50 AM CET | Health & Medicine

Press release from: SMi Group

SMi's Paediatric Clinical Trials conference held on the 21st &

Many drugs which are prescribed to children have not been adequately studied in the paediatric population. Pharmaceutical companies are now required to produce medicines specifically aimed at 0-17 year olds which has resulted in an increase in paediatric clinical trials. Trials in children are tightly regulated and have both operational and ethical challenges which need to be overcome.

Don’t miss out on this fantastic opportunity to network with experts in the field that includes:

Klaus Rose, Paediatric Drug Development Consultant, Klausrose Consulting
Lisa Moore-Ramdin, Senior Medical Advisor, Paediatric Vaccines, GlaxoSmithKline
Sabine Desset-Brethes, Project Leader, Pharmaceutical & Analytical Development, Novartis
Georg Schmitt, Head of Toxicology & NCS Paediatrics, F. Hoffman-La Roche
David McIntosh, Global Scientific Affairs Senior Expert, Novartis
Stephen Heaton, Head of Safety Risk Management Planning & Coordination, Bayer Healthcare
Thomas Hassall, Senior Director, Regulatory Policy & Intelligence, Abbott Laboratories
Ashley Strougo, Scientist, PK Modelling & Simulation, Astellas
Joseph Standing, Paediatric Clinical Lecturer, School of Pharmacy, University College London
Dirk Matthys, Head of Paediatrics, Ghent University Hospital
Hans Stoetter, Head of the Paediatric Working Group, Swissmedic

There will also be two interactive pre-conference workshops held on the 20th March, hosted by Gaynor Anders, Vice President/Head of Global Operations MMG and Klaus Rose – Managing Director Klausrose Consulting

For more information and to book your place visit http://www.smi-online.co.uk/paediatric-trials20.asp

Alternatively, contact Andrew Gibbons at Tel: +44 (0)20 7827 6156 or Email: agibbons@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group
30 Great Guildford Street
SE1 0HS

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi's Paediatric Clinical Trials conference held on the 21st & 22nd March 2012, London here

News-ID: 202004 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Paediatric

Paediatric Vaccine Market - Industry Trends and Forecast to 2029
The Global Paediatric Vaccine Market Growth at a rate of 9.80% in the forecast period 2022 to 2029. Global Paediatric Vaccine Market Size The paediatric vaccines are used to prevent children from contracting several infectious and non-infectious diseases. The prevalence of chronic diseases is escalating the growth of the paediatric vaccine market. Global paediatric vaccine market was valued at USD 35.74 billion in 2021 and is expected to reach USD 68.78 billion by
Research focused on the Paediatric Vaccine Market forecast to 2026
Paediatric Vaccine Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. "Paediatric
Paediatric Sports Medicine Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Paediatric Sports Medicine Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html   Paediatric specialist treat the unique sports-related medical
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Paediatric Healthcare-Rising Prevalence of Chronic Diseases and Increasing Deman …
Market Research Future published a Half Cooked research report on “Middle East & Africa Paediatric Healthcare Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants
Improving Access to Innovative Paediatric Medicines
Paediatric Clinical Trials 2018 recognises the continuing need for education amongst Clinical Research Professionals responsible for the activities at the research site or institution. Next year's event will focus on assisting Research Professionals in improving their skills and their understanding of the responsibilities of conducting clinical research in the paediatric population. Through a series of presentations, practical applications and a supporting workshop facilitated by clinical research professionals, information will be presented